跳至主要内容
临床试验/NCT05082077
NCT05082077Enrolling By Invitation不适用

Global Utilization and Registry Database for Improved Preservation of Donor Livers

Paragonix Technologies22 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2022年3月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
2,000
试验地点
22
主要终点
Early allograft dysfunction

研究概览

简要总结

The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients

详细描述

GUARDIAN-Liver is a post-market, observational registry of adult and pediatric liver transplant recipient patients whose donor liver was preserved and transported within the LIVERguard. The data is being collected retrospectively from medical records of patients already transplanted before the initiation of the registry and any new patients who meet the eligibility criteria.

About 2,000 male and female subjects meeting the study inclusion and exclusion criteria will be enrolled into the study at about 20 clinical sites.

Candidates that fit the eligibility criteria and have had their donor liver transported with a Paragonix product or a standard of care method can be enrolled. The baseline characteristics and outcomes of the two groups will be compared.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Donor and donor liver matched to the recipient based upon institutional medical practice
  • Registered male or female liver transplant candidates

排除标准

  • Donor and donor liver that do not meet institutional clinical requirements for transplantation
  • Living donors

研究组 & 干预措施

LIVERguard patient

Patients whose donor liver was transported with the LiverGuard device.

干预措施: LIVERguard (Device)

Standard Transport Patients

Patients whose donor liver was transported with a method other than the LiverGuard

结局指标

主要结局

Early allograft dysfunction

时间窗: 7 days post transplant

The percentage of subjects in each cohort who early allograft failure post-transplant

Survival

时间窗: Transplant through 1 year post-transplant

The percentage of subjects in each cohort who survive through 1 year post-transplant

Length of ICU stay

时间窗: 1 year

How many days the patient stayed in the ICU post-transplant

Length of Stay

时间窗: 1 year

How many days the patient stays in the hospital post-transplant

Rejection

时间窗: Post-transplant through 1 year post

The percentage of subjects in each cohort who experience rejection post-transplant

Primary Non-function

时间窗: Post transplant to 7 days post-transplant

The percentage of subjects in each cohort who experience primary non-function post-transplant

Graft Failure

时间窗: Post-transplant through 1 year post

The percentage of subjects in each cohort who develop graft failure post-transplant

次要结局

  • Hospitalizations(post-transplant through 1 year)
  • Biliary complications(post-transplant through 1 year post-transplant)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验